Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVI
Primary Purpose
Acute Lymphoblastic Leukemia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cognitive training
Sponsored by
About this trial
This is an interventional supportive care trial for Acute Lymphoblastic Leukemia focused on measuring Cognitive intervention, Survivors, Childhood ALL
Eligibility Criteria
Inclusion Criteria:
- Currently enrolled and receiving treatment for acute lymphoblastic leukemia (ALL) on the TOTXVI therapy protocol at St. Jude Children's Research Hospital
- At least 4 years of age at the time of randomization
- Primary language is English
- Parent/legal guardian/caregiver that speaks English available to assist in participant's training
Exclusion Criteria:
- Significant cognitive impairment as determined by either an IQ of ≤ 70 or by clinician judgment
- Major sensory or motor impairment that would preclude valid cognitive testing
- Major psychological condition that would preclude completion of the intervention
- History of significant CNS injury or disease predating or unrelated to cancer diagnosis
- Documented ADHD predating cancer diagnosis
Sites / Locations
- St. Jude Children's Research Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Cognitive Training
Standard-of-Care
Arm Description
Participants will participate in computer-based cognitive training at the end of therapy.
At the end of therapy, participants will participate in the current standard-of-care which does not include computer-based cognitive training.
Outcomes
Primary Outcome Measures
Change in working memory
The magnitude and standard deviation of pre- to post-change in Spatial Span Backward will be estimated for each group and for the overall group.
Secondary Outcome Measures
Full Information
NCT ID
NCT03187977
First Posted
June 13, 2017
Last Updated
March 24, 2022
Sponsor
St. Jude Children's Research Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03187977
Brief Title
Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVI
Official Title
Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVI: A Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
August 3, 2017 (Actual)
Primary Completion Date
October 13, 2021 (Actual)
Study Completion Date
October 13, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
St. Jude Children's Research Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Computer-based cognitive training has been found to be helpful for improving attention and working memory in pediatric and adult patients with existing cognitive difficulties. A previous study was conducted at St. Jude Children's Research Hospital with survivors of childhood cancer who were experiencing difficulties with attention and/or working memory. Findings from that study indicated that the use of Cogmed, computer-based cognitive training, is effective in improving attention and working memory in survivors.
Researchers want to learn whether Cogmed intervention completed at the end of therapy for acute lymphoblastic leukemia will be effective for all survivors (i.e., regardless of whether they have existing difficulties).
PRIMARY OBJECTIVES:
To evaluate the overall participation rate in a randomized, standard-of-care controlled trial of computerized cognitive intervention administered at the end of TOTXVI therapy.
To estimate the study completion rate in a randomized, standard-of-care controlled trial of computerized cognitive intervention administered at the end of TOTXVI therapy.
To estimate the compliance rate for participants randomized to the intervention arm of a computerized cognitive intervention administered at the end of TOTXVI therapy.
To estimate the standard deviation for the overall cohort on a measure of working memory.
To use neuroimaging data collected in the context of the Total Therapy XVI trial to explore candidate biomarkers predictive of response to the computerized cognitive intervention.
Detailed Description
Participants enrolled on the TOTXVI protocol at SJCRH will be randomized to either complete the Cogmed intervention at the end of their therapy, or to a standard-of-care condition.
Cogmed is a computer-based cognitive training program that consists of rotating exercises that train attention and working memory. The exercises are presented in a child-friendly, game-like format. Training is completed at home in 25 sessions for 15-45 minutes each weekday for 5-9 weeks. A research team member serves as a coach who monitors progress and provides support through weekly phone calls with study participants and their parents/guardians. Information regarding compliance and performance is tracked over the internet and used to tailor feedback during weekly telephone coaching.
Neurocognitive assessments will be conducted at baseline, immediate-post (3-4 months after baseline), and 8 month follow-up (12 months after baseline).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Lymphoblastic Leukemia
Keywords
Cognitive intervention, Survivors, Childhood ALL
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be randomized to either the intervention group to receive cognitive training or to the standard of care group who will not receive cognitive training.
Masking
Outcomes Assessor
Masking Description
The study examiner (clinical research assistants or psychological examiners) will not know which group of participants is associated with each arm.
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cognitive Training
Arm Type
Active Comparator
Arm Description
Participants will participate in computer-based cognitive training at the end of therapy.
Arm Title
Standard-of-Care
Arm Type
No Intervention
Arm Description
At the end of therapy, participants will participate in the current standard-of-care which does not include computer-based cognitive training.
Intervention Type
Behavioral
Intervention Name(s)
Cognitive training
Other Intervention Name(s)
Cogmed
Intervention Description
Cogmed is a computer-based cognitive training program that consists of rotating exercises that train attention and working memory. The exercises are presented in a child-friendly, game-like format. The program is completed at home for 15-45 minutes each weekday for 5-9 weeks.
Primary Outcome Measure Information:
Title
Change in working memory
Description
The magnitude and standard deviation of pre- to post-change in Spatial Span Backward will be estimated for each group and for the overall group.
Time Frame
Prior to intervention (baseline) and post intervention (up to one year later)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
4 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Currently enrolled and receiving treatment for acute lymphoblastic leukemia (ALL) on the TOTXVI therapy protocol at St. Jude Children's Research Hospital
At least 4 years of age at the time of randomization
Primary language is English
Parent/legal guardian/caregiver that speaks English available to assist in participant's training
Exclusion Criteria:
Significant cognitive impairment as determined by either an IQ of ≤ 70 or by clinician judgment
Major sensory or motor impairment that would preclude valid cognitive testing
Major psychological condition that would preclude completion of the intervention
History of significant CNS injury or disease predating or unrelated to cancer diagnosis
Documented ADHD predating cancer diagnosis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lisa M. Jacola, PhD
Organizational Affiliation
St. Jude Children's Research Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
St. Jude Children's Research Hospital
City
Memphis
State/Province
Tennessee
ZIP/Postal Code
38105
Country
United States
12. IPD Sharing Statement
Links:
URL
http://stjude.org
Description
St. Jude Children's Research Hospital
URL
http://stjude.org/protocols
Description
Clinical Trials Open at St. Jude
Learn more about this trial
Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVI
We'll reach out to this number within 24 hrs